Spiderwort is developing a novel biomaterial that will offer new avenues in regenerative medicine. We are using plant derived cellulose to create a variety of scaffold architectures. Currently, we are in the pre-clinical stage of this product and our promising results demonstrate that this new biomaterial is highly biocompatible and induceangiogenesis (blood vessel generation inside the scaffold).

Biotechnology

Health Care

Spiderwort Inc.

Charles M. Cuerrier

Stephen Hanson

Scott Jarvis, Virtual CFO

Michelle Masson

Andrew Pelling

The Leadership Team at Spiderwort Inc. is responsible for setting the strategic direction of the company, overseeing the development of innovative biomaterials for regenerative medicine, and ensuring financial sustainability. Comprised of key roles—including the Co-founder and Chief Scientific Officer, CEO and Co-founder, and Chief Financial Officer—this team drives research initiatives, fosters partnerships, and navigates pre-clinical progress to bring plant-derived cellulose scaffolds to market.

Leadership Team

Research and Development

Leadership Team

About

Team members

Other teams at Spiderwort Inc.

Research and Development